{"product_id":"wound-care-biologics-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","title":"Wound Care Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028","description":"\u003cp\u003eWound Care Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028\u003cbr\u003e\nMarket Overview 2023-2028:\u003c\/p\u003e\n\n\u003cp\u003eThe global wound care biologics market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 8.5% during 2023-2028.\u003c\/p\u003e\n\n\u003cp\u003eWound care biologics refer to drugs extracted or semi-synthesized from natural sources which are used for controlling and healing infections. Wound healing is a complex process involving inflammation, accumulation of fibrous tissue, deposition of collagen, formation of epithelial cell layers and other disruptions. Biologic wound healing treatments possess the ability to restore the natural repair mechanism through active biological agents. For instance, plant-derived active biomolecules with antimicrobial, anti-inflammatory or antioxidant properties have proven efficacious in advancing the wound-healing process. Some of the recent technological advancements made in the field of wound healing include skin substitutes, bio-membranes, scaffolds, hydroconductive dressings and biologics.\u003c\/p\u003e\n\n\u003cp\u003eChronic skin wounds can be caused due to burns, skin cancers, infections, trauma or an underlying medical condition such as diabetes. With the growing prevalence of these ailments along with the expanding geriatric population, there has been a rise in the demand for treatments that can accelerate wound healing and facilitate a speedy recovery. Along with this, several initiatives have been undertaken by governments across the globe to create awareness about the benefits of wound care biologics among patients. Apart from this, manufacturers are also developing next-generation, cost-effective and high-quality biologics to make them more accessible. Moreover, many research and healthcare centers are entering into partnerships to modernize wound care treatments and develop innovative drugs for healing wounds. For example, researchers are focusing on integrating antimicrobial compounds into the wound dressing itself. These materials combine traditional wound dressings such as hydrogels or foams with antimicrobial compounds such as betaine, silver, chitin, or polyhexamethylene biguanide.\u003c\/p\u003e\n\n\u003cp\u003eKey Market Segmentation:\u003cbr\u003e\nIMARC Group provides an analysis of the key trends in each sub-segment of the global wound care biologics market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product, wound type, application and end-user.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Product:\u003c\/p\u003e\n\n\u003cp\u003eBiologic Skin Substitutes\u003cbr\u003e\nHuman Donor Tissue-Derived Products\u003cbr\u003e\nAcellular Animal-Derived Products\u003cbr\u003e\nBiosynthetic Products\u003cbr\u003e\nTopical Agents\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Wound Type:\u003c\/p\u003e\n\n\u003cp\u003eUlcers\u003cbr\u003e\nDiabetic Foot Ulcers\u003cbr\u003e\nVenous Ulcers\u003cbr\u003e\nPressure Ulcers\u003cbr\u003e\nOthers\u003cbr\u003e\nSurgical and Traumatic Wounds\u003cbr\u003e\nBurns\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Application:\u003c\/p\u003e\n\n\u003cp\u003eAcute Wound\u003cbr\u003e\nChronic Wound\u003cbr\u003e\nSurgical Wound\u003cbr\u003e\n \u003cbr\u003e\nBreakup by End-User:\u003c\/p\u003e\n\n\u003cp\u003eHospitals\u003cbr\u003e\nASCs\u003cbr\u003e\nBurn Centres and Wound Clinics\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Region:\u003c\/p\u003e\n\n\u003cp\u003eAsia Pacific\u003cbr\u003e\nEurope\u003cbr\u003e\nNorth America\u003cbr\u003e\nMiddle East and Africa\u003cbr\u003e\nLatin America\u003cbr\u003e\n \u003cbr\u003e\nCompetitive Landscape:\u003cbr\u003e\nThe report has also analysed the competitive landscape of the market with some of the key players being Smith \u0026amp; Nephew, Mölnlycke Health Care, Integra lifesciences, Osiris Therapeutics, Avita Medical, ConvaTec Group, Cytori Therapeutics, Mylan, Johnson \u0026amp; Johnson, Leap Therapeutics, Nuo Therapeutics, Mallinckrodt, Wright Medical, Mimedx Group and Solsys Medical, etc.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered in This Report:\u003cbr\u003e\nHow has the global wound care biologics market performed so far and how will it perform in the coming years?\u003cbr\u003e\nWhat are the key regional markets in the global wound care biologics industry?\u003cbr\u003e\nWhat has been the impact of COVID-19 on the global wound care biologics industry?\u003cbr\u003e\nWhat is the breakup of the market based on the product?\u003cbr\u003e\nWhat is the breakup of the market based on the wound type?\u003cbr\u003e\nWhat is the breakup of the market based on the application?\u003cbr\u003e\nWhat is the breakup of the market based on the end-user?\u003cbr\u003e\nWhat are the various stages in the value chain of the global wound care biologics industry?\u003cbr\u003e\nWhat are the key driving factors and challenges in the global wound care biologics industry?\u003cbr\u003e\nWhat is the structure of the global wound care biologics industry and who are the key players?\u003cbr\u003e\nWhat is the degree of competition in the global wound care biologics industry?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"July, 2023 \/ 146 Pages \/ MCW16231058","offer_id":47647259590962,"sku":null,"price":2999.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/wound-care-biologics-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}